Atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.0582 mg / phenobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg Extended Release Oral Tablet [Hyosophen]
RxNorm 1047775

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1047775 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.0582 mg / phenobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg Extended Release Oral Tablet [Hyosophen].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.0582 mg / phenobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg Extended Release Oral Tablet [Hyosophen]
AUI:12369494
View
TMSY
Atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.0582 mg / PHENobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg Extended Release Oral Tablet [Hyosophen]
AUI:12382869
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBD

Semantic Branded Drug (SBD):
Atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.0582 mg / phenobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg Extended Release Oral Tablet [Hyosophen]
(Atom ID: 12369494)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.0582 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet [Hyosophen]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1047775
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12369494
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1047775
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1046994} 153971
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1046996} 9603
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{336053} 8134
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1046994} 1223
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1046996} 9601
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{336053} 8134
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1046994} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1046996} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{336053} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete
TMSY

Tall Man Lettering Synonym (TMSY):
Atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.0582 mg / PHENobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg Extended Release Oral Tablet [Hyosophen]
(Atom ID: 12382869)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.0582 MG / PHENobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet [Hyosophen]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1047775
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12382869
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
TMSY
Tall Man Lettering Synonym (Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.)
Source Code
1047775
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.